在线国产一区二区_成人黄色片在线观看_国产成人免费_日韩精品免费在线视频_亚洲精品美女久久_欧美一级免费在线观看

您現(xiàn)在的位置: > Language Tips > Audio & Video > Special Speed News  
 





  Once-daily pill could simplify HIV treatment
[ 2006-02-06 15:57 ]


I’m Steve Ember with the VOA Special English Health Report.


Myers Squibb and Gilead Sciences have combined many H.I.V. drugs into a single pill
Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and H.I.V./AIDS, for example, are all treated with combinations of drugs.

But that can mean a lot of pills to take. It would be simpler if drug companies combined all the medicines into a single pill, taken just once a day.

Now, two companies say they have done that for people just starting treatment for H.I.V., the virus that causes AIDS. The companies are Bristol-Myers Squibb and Gilead Sciences.

They have developed a single pill that combines three drugs currently on the market. Bristol-Myers Squibb sells one of them under the name Sustiva. Gilead combined the others, Emtriva and Viread, into a single pill in two thousand four.

Combining drugs involves more than technical issues. It also involves issues of competition if the drugs are made by different companies. The new once-daily pill is the result of what is described as the first joint venture agreement of its kind in the treatment of H.I.V.

In January the New England Journal of Medicine published a study of the new pill. Researchers compared its effectiveness to that of the widely used combination of Sustiva and Combivir. Combivir contains two drugs, AZT and 3TC. The researchers say that after one year of treatment, the new pill suppressed H.I.V. levels in more patients and with fewer side effects.

Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine in Baltimore, Maryland, led the research. He is a paid adviser to Gilead and Bristol-Meyers Squibb as well as the maker of Combivir, GlaxoSmithKline.

GlaxoSmithKline reacted to the findings by saying that a single study is of limited value. It says the effectiveness of Combivir has been shown in each of more than fifty studies.

The price of the new once-daily pill has not been announced. But Gilead and Bristol-Myers Squibb say they will provide it at reduced cost to developing countries.

They plan in the next few months to ask the United States Food and Drug Administration to approve the new pill.

There are limits to who could take it because of the different drugs it contains. For example, pregnant women are told not to take Sustiva because of the risk of birth disorders.

Experts say more than forty million people around the world are living with H.I.V.

This VOA Special English Health Report was written by Cynthia Kirk. Read and listen to our reports at voaspecialenglish.com. I’m Steve Ember.

Vocabulary

 

 

 
 
 




主站蜘蛛池模板: 欧美一级在线免费观看 | 欧美激情欧美激情在线五月 | 中文一区 | 一级毛片国产 | 日本高清中文字幕 | 最近最新中文字幕 | 亚洲精品一区二区三区蜜桃久 | 九九综合九九 | 亚洲精品一区二区网址 | 国产精品久久久久久妇女6080 | 欧美日韩黄色一级片 | 亚洲成人免费视频 | 丁香五月网久久综合 | 九九热精品免费视频 | 青草青草久热精品视频在线观看 | 久久精品国产99国产精品 | 日韩视频一区二区三区 | 国产成人福利视频 | 亚洲成人免费视频在线观看 | 黄色免费在线播放 | 精品日韩在线 | 国产精品久久 | 91免费看 | 国产永久免费 | 自拍偷拍第一页 | 理论片免费在线观看 | 国内精品一区二区 | 久久综合色88 | 日韩精品一区二区三区 | 日韩精品在线网站 | 国产高清在线精品一区二区三区 | 热99re久久免费视精品频软件 | 欧美精品一区二区在线观看 | 国产精品地址 | 久久久久999 | 天天草夜夜操 | 亚洲午夜在线 | 精品中文字幕一区 | 色偷偷噜噜噜亚洲男人 | 欧美男人的天堂 | 一区二区影视 |